Mecure Industries PLC (NGX:MECURE)
Nigeria flag Nigeria · Delayed Price · Currency is NGN
56.20
0.00 (0.00%)
At close: Aug 5, 2026

Mecure Industries Statistics

Total Valuation

NGX:MECURE has a market cap or net worth of NGN 224.80 billion. The enterprise value is 283.90 billion.

Market Cap224.80B
Enterprise Value 283.90B

Important Dates

The last earnings date was Wednesday, July 29, 2026.

Earnings Date Jul 29, 2026
Ex-Dividend Date Apr 24, 2026

Share Statistics

NGX:MECURE has 4.00 billion shares outstanding.

Current Share Class 4.00B
Shares Outstanding 4.00B
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 87.29%
Owned by Institutions (%) n/a
Float 508.29M

Valuation Ratios

The trailing PE ratio is 31.17.

PE Ratio 31.17
Forward PE n/a
PS Ratio 2.64
PB Ratio 10.21
P/TBV Ratio 10.21
P/FCF Ratio n/a
P/OCF Ratio 59.86
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 39.37
EV / Sales 3.33
EV / EBITDA 11.11
EV / EBIT 14.59
EV / FCF n/a

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.00.

Current Ratio 1.12
Quick Ratio 0.57
Debt / Equity 3.00
Debt / EBITDA 2.59
Debt / FCF -3.15
Interest Coverage 1.94

Financial Efficiency

Return on equity (ROE) is 37.84% and return on invested capital (ROIC) is 21.28%.

Return on Equity (ROE) 37.84%
Return on Assets (ROA) 14.73%
Return on Invested Capital (ROIC) 21.28%
Return on Capital Employed (ROCE) 33.01%
Weighted Average Cost of Capital (WACC) 13.54%
Revenue Per Employee 437.32M
Profits Per Employee 36.98M
Employee Count195
Asset Turnover 1.03
Inventory Turnover 3.91

Taxes

In the past 12 months, NGX:MECURE has paid 1.79 billion in taxes.

Income Tax 1.79B
Effective Tax Rate 19.89%

Stock Price Statistics

The stock price has increased by +222.99% in the last 52 weeks. The beta is 1.76, so NGX:MECURE's price volatility has been higher than the market average.

Beta (5Y) 1.76
52-Week Price Change +222.99%
50-Day Moving Average 84.77
200-Day Moving Average 68.36
Relative Strength Index (RSI) 3.06
Average Volume (20 Days) 800,148

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, NGX:MECURE had revenue of NGN 85.28 billion and earned 7.21 billion in profits. Earnings per share was 1.80.

Revenue85.28B
Gross Profit 28.08B
Operating Income 19.46B
Pretax Income 9.00B
Net Income 7.21B
EBITDA 25.55B
EBIT 19.46B
Earnings Per Share (EPS) 1.80
Full Income Statement

Balance Sheet

The company has 7.07 billion in cash and 66.17 billion in debt, with a net cash position of -59.10 billion or -14.77 per share.

Cash & Cash Equivalents 7.07B
Total Debt 66.17B
Net Cash -59.10B
Net Cash Per Share -14.77
Equity (Book Value) 22.02B
Book Value Per Share 5.51
Working Capital 4.46B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.76 billion and capital expenditures -24.77 billion, giving a free cash flow of -21.02 billion.

Operating Cash Flow 3.76B
Capital Expenditures -24.77B
Depreciation & Amortization 6.09B
Net Borrowing 20.07B
Free Cash Flow -21.02B
FCF Per Share -5.25
Full Cash Flow Statement

Margins

Gross margin is 32.92%, with operating and profit margins of 22.82% and 8.46%.

Gross Margin 32.92%
Operating Margin 22.82%
Pretax Margin 10.56%
Profit Margin 8.46%
EBITDA Margin 29.96%
EBIT Margin 22.82%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 0.57%.

Dividend Per Share 0.32
Dividend Yield 0.57%
Dividend Growth (YoY) 113.33%
Years of Dividend Growth n/a
Payout Ratio 8.32%
Buyback Yield n/a
Shareholder Yield 0.57%
Earnings Yield 3.21%
FCF Yield -9.35%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

NGX:MECURE has an Altman Z-Score of 3.55 and a Piotroski F-Score of 4.

Altman Z-Score 3.55
Piotroski F-Score 4